Cargando…

Longitudinal trajectories of Alzheimer’s ATN biomarkers in elderly persons without dementia

BACKGROUND: Models of Alzheimer’s disease (AD) pathophysiology posit that amyloidosis [A] precedes and accelerates tau pathology [T] that leads to neurodegeneration [N]. Besides this A-T-N sequence, other biomarker sequences are possible. This current work investigates and compares the longitudinal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Meng-Shan, Ji, Xi, Li, Jie-Qiong, Xu, Wei, Wang, Hui-Fu, Tan, Chen-Chen, Dong, Qiang, Zuo, Chuan-Tao, Tan, Lan, Suckling, John, Yu, Jin-Tai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216714/ https://www.ncbi.nlm.nih.gov/pubmed/32393375 http://dx.doi.org/10.1186/s13195-020-00621-6

Ejemplares similares

Disease trajectories in elders with suspected non-Alzheimer’s pathophysiology and its comparison with Alzheimer’s disease pathophysiology: a longitudinal study
por: Li, Jie-Qiong, et al.
Publicado: (2023)

Clinical and biomarker trajectories in sporadic Alzheimer's disease: A longitudinal study
por: Wang, Hui‐Fu, et al.
Publicado: (2020)

A panel of blood lipids associated with cognitive performance, brain atrophy, and Alzheimer's diagnosis: A longitudinal study of elders without dementia
por: Ma, Ya‐Hui, et al.
Publicado: (2020)

Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort
por: Ingala, Silvia, et al.
Publicado: (2021)

Longitudinal change in ATN biomarkers in cognitively normal individuals
por: Ebenau, Jarith L., et al.
Publicado: (2022)

Genome-wide association study of white matter hyperintensity volume in elderly persons without dementia
por: Guo, Yu, et al.
Publicado: (2020)

Metabolically healthy obesity reduces the risk of Alzheimer’s disease in elders: a longitudinal study
por: Ma, Ling-Zhi, et al.
Publicado: (2019)

Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration
por: Tan, Meng-Shan, et al.
Publicado: (2021)

Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease
por: Duong, Michael Tran, et al.
Publicado: (2022)

Evaluation of the ATN model in a longitudinal memory clinic sample with different underlying disorders
por: Eckerström, C., et al.
Publicado: (2021)

Multipredictor risk models for predicting individual risk of Alzheimer’s disease
por: Hou, Xiao-He, et al.
Publicado: (2023)

Surgical Outcomes of Myopic Foveoschisis According to the ATN Classification System
por: Fang, Dong, et al.
Publicado: (2022)

Identification of preclinical dementia according to ATN classification for stratified trial recruitment: A machine learning approach
por: Koychev, Ivan, et al.
Publicado: (2023)

Plasma amyloid, tau, and neurodegeneration biomarker profiles predict Alzheimer's disease pathology and clinical progression in older adults without dementia
por: Shen, Xue‐Ning, et al.
Publicado: (2020)

Prediction of Alzheimer’s disease biomarker status defined by the ‘ATN framework’ among cognitively healthy individuals: results from the EPAD longitudinal cohort study
por: Calvin, Catherine M., et al.
Publicado: (2020)

The association of serum uric acid with cognitive impairment and ATN biomarkers
por: Huang, Shan, et al.
Publicado: (2022)

Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study
por: Chen, Shi-Dong, et al.
Publicado: (2021)

Exploring the ATN classification system using brain morphology
por: Heinzinger, Nils, et al.
Publicado: (2023)

Head-to-head comparison of plasma and PET imaging ATN markers in subjects with cognitive complaints
por: Lu, Jiaying, et al.
Publicado: (2023)

Prognostic value of ATN Alzheimer biomarkers: 60‐month follow‐up results from the Argentine Alzheimer's Disease Neuroimaging Initiative
por: Allegri, Ricardo F., et al.
Publicado: (2020)

Polypharmacy trajectories among older women with and without dementia: A longitudinal cohort study
por: Thapaliya, Kailash, et al.
Publicado: (2021)

TREML2 Mutation Mediate Alzheimer’s Disease Risk by Altering Neuronal Degeneration
por: Song, Ya-Nan, et al.
Publicado: (2019)

Prognostic value of amyloid/tau/neurodegeneration (ATN) classification based on diagnostic cerebrospinal fluid samples for Alzheimer’s disease
por: Delmotte, Koen, et al.
Publicado: (2021)

Age-related hearing loss accelerates cerebrospinal fluid tau levels and brain atrophy: a longitudinal study
por: Xu, Wei, et al.
Publicado: (2019)

Longitudinal trajectory of Amyloid‐related hippocampal subfield atrophy in nondemented elderly
por: Zhang, Liwen, et al.
Publicado: (2020)

ATN profile classification across two independent prospective cohorts
por: Peretti, Débora E., et al.
Publicado: (2023)

A novel variant in the HX repeat motif of ATN1 in a Chinese patient with CHEDDA syndrome and literature review
por: Luo, Sukun, et al.
Publicado: (2022)

FDG-PET as an independent biomarker for Alzheimer’s biological diagnosis: a longitudinal study
por: Ou, Ya-Nan, et al.
Publicado: (2019)

MAPT rs242557 variant is associated with hippocampus tau uptake on (18)F-AV-1451 PET in non-demented elders
por: Shen, Xue-Ning, et al.
Publicado: (2019)

Discordant Alzheimer's neurodegenerative biomarkers and their clinical outcomes
por: Guo, Yu, et al.
Publicado: (2020)

VALIDATION OF THE RECENTLY DEVELOPED ATN CLASSIFICATION AND GRADING SYSTEM FOR MYOPIC MACULOPATHY
por: Ruiz-Medrano, Jorge, et al.
Publicado: (2020)

ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project
por: Ebenau, Jarith L., et al.
Publicado: (2020)

Mild behavioral impairment correlates of cognitive impairments in older adults without dementia: mediation by amyloid pathology
por: Sun, Yan, et al.
Publicado: (2021)

Dynamic changes of CSF sPDGFRβ during ageing and AD progression and associations with CSF ATN biomarkers
por: Wang, Jun, et al.
Publicado: (2022)

Longitudinal plasma phosphorylated tau 181 tracks disease progression in Alzheimer’s disease
por: Chen, Shi-Dong, et al.
Publicado: (2021)

Genome-wide association study identifies CBFA2T3 affecting the rate of CSF Aβ(42) decline in non-demented elders
por: Dou, Kai-Xin, et al.
Publicado: (2019)

Neuropsychiatric Inventory data in a Belgian sample of elderly persons with and without dementia
por: Squelard, Gilles P, et al.
Publicado: (2012)

Heart fatty acid-binding protein is associated with phosphorylated tau and longitudinal cognitive changes
por: Fu, Yan, et al.
Publicado: (2022)

Developmental Trajectories and Predictors of Incident Dementia among Elderly Taiwanese People: A 14-Year Longitudinal Study
por: Fan, Yen-Chun, et al.
Publicado: (2023)

Prognostic value of imaging-based ATN profiles in a memory clinic cohort
por: Peretti, Débora E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fq9g3oe4i0chq7euj91k3clnaf